vTv Therapeutics has secured an $80 million PIPE to fund the ongoing CATT1 phase 3 trial and continued development...

Simcere has launched Quviviq (daridorexant) in mainland China for adult insomnia, adding one of the leading dual orexin receptor...

Europe’s drug regulator has issued a positive opinion for dupilumab in chronic spontaneous urticaria, recommending approval for adults and...

Arecor Therapeutics has struck a co-development deal with Sequel Med Tech to pair AT278, its ultra-concentrated (500 U/mL), ultra-rapid...

Basilea Pharmaceutica has secured a BARDA contract novation to support the development of ceftibuten–ledaborbactam etzadroxil, an investigational oral beta-lactam/beta-lactamase...

Roquette has closed the acquisition of IFF Pharma Solutions and reported first-half 2025 results showing a step-change in mix...

Verona Pharma shareholders have approved Merck’s proposed acquisition of the company for $107 per American Depositary Share, valuing the...

Eurobio Scientific reported first-half 2025 revenue of €81.2 million, up 10% year over year, with proprietary products rising to...

TG Therapeutics reported six-year outcomes for Briumvi (ublituximab) from the ULTIMATE I & II Phase 3 programs at ECTRIMS...

Cellectar Biosciences has selected Evestia Clinical as a full-service CRO for a Phase 1b study of CLR 125 in...